MaximizeBelief

$docn market makers trying to steal all the options premium.

I predict that $ASXM finishes green today.

This is how Wall St makes money. Waits for retail to panic sell and buy at the low for the year. Ride it back up to over $200 and then buyout. They are experts. $AXSM

Get all the capitulation and panic selling out of the way $AXSM. Hard to believe we are here. Almost like ADA approval never happened, pipeline non-existent and Auvelity sales going backwards.

$AXSM now worth less than $6.5B. They reaffirmed their peak sales of $8B for Auvelity alone. Apparently the market doesn't believe it.

That may have been the bottom. Hit $131 now positive for the day plus huge call volume and buying volume. It's possible we could get a BO announcement on Monday. We'll see. $AXSM

$ABOS fail once again proves how difficult Alzheimers is to treat and why $AXSM is the only play, now on sale 50% off!

What is this green I see? $AXSM

I would imagine that $AXSM management would have some thoughts/commentary on why they believe their share price has fallen $120 per share (46%) in 4 months during the earnings call.

$AXSM now worth under $8B. This is getting scooped up by big pharma. Classic buyout manipulation. See $SLN. 50% haircut before buyout.

$vera serious market disconnect with $60 and $70 PTs. Trades under $30 now.

$BZRD starting to move again. Probably because peptides are getting approved soon. $HIMS

Annoying that $docn gets lumped in with the other neoclouds and hyperscalers. They are profitable and growing rapidly. When will the market finally re-rate?

This is $AXSM over the past month. Only 2 green days.

The chart on the left is $AXSM. The chart on the right is $SLN. Draw your own conclusions.

Just like $SLN got cut on half then 130% buyout premium, I expect the same for $AXSM. $350+

$axsm only a market cap of a litte over $8B. So ridiculously cheap. Big Pharma is licking its chops. They are not going to sell cheap--no reason to. Was worth over $13B four months ago. $5B wiped out. Does that make any sense? What changed to wipe out $5B?

Even the street low price target of $34 (which is ridiculous) is $6-7 higher than we are today. This is the worst case scenario. Peak pessimism. $VERA

$AXSM gets bought for $350. They can command a 100% premium with their commercial and late stage pipeline.

It is insane that $IBRX is worth more than $AXSM. $AXSM has a path to $16B in peak pipeline revenue. Trading under $10B. Annual revenues almost $1B already and will be cash flow positive very soon.